Introduction
Bleeding occurs in 2%-12% cases after biliary endoscopic sphincterotomy (ES). 1 Several techniques have been described to achieve hemostasis: adrenalin injection, thermal coagulation, and glue. 1 However, with the spread of fully covered removable self-expandable metal stent (FCSEMS), its temporary deployment to achieve hemostasis by mechanical compression on the papilla has become a standard treatment. [1] [2] [3] 
Case
A 55-year-old man was admitted to hospital for jaundice and fever. Computed tomography (CT) scan showed dilatation of biliary tree and a mass of the pancreatic head. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) and biliary drainage by endoscopic retrograde cholangiopancreatography (ERCP) with stenting of common bile duct (CBD) (WallFlex ® , 6 cm long, 10 mm large, fully covered; Boston Scientific, Marlborough, MA, USA) were performed to achieve biliary drainage as bridge to surgery. An ES was performed before stenting to reduce the risk of post-ERCP pancreatitis. After 12 h, the patient presented bleeding per rectum and hemorrhagic shock. Hemoglobin level dropped to 5 g/dL. After resuscitation and blood transfusions, duodenoscopy was performed. A firm clot occluding the duodenum was present with concomitant gastric stasis. Removal of clots with Dormia basket exposed an active bleeding on the right edge of the previous sphincterotomy. The bleeding occurred despite presence of covered metallic stent. Most probably, the self-expandable metal stent (SEMS) failed to achieve water-tight tamponade due to the large size of ES (Figures 1 and 2) . Therefore, the stent was removed to better localize the bleeding. Temporary hemostasis was successfully achieved by submucosal injection of 20 cc of epinephrine (1:20000) on the edges and on the roof of sphincterotomy (Figure 3) . A new SEMS was deployed to guarantee biliary drainage and definitive hemostasis (Figures 4 and 5) . Recovery was uneventful, and patient was discharged after 2 days.
Discussion
ES before metallic stenting for pancreatic cancer is associated with lower incidence of post-procedural pancreatitis; 4 however, bleeding and perforation may occur anyway. Meanwhile, in case of unresectable pancreatic cancer, ES is not advised. 5 In the event of bleeding, covered metallic stent is usually considered as the last endoscopic resort to achieve hemostasis before undergoing embolization and/or surgery for bleeding following ES or duodenal ulcer 6 We believe that in case of bleeding, a long (6 cm) FCSEMS may be useful to achieve definitive hemostasis avoiding in the meantime spontaneous migration frequent in the absence of a biliary stricture. The shorter the stent (4 cm), the higher the risk of migration. Epinephrine injection may be useful to induce a temporary hemostasis and to improve visibility in case of active bleeding coupled with FCSEMS deployment to guarantee definitive hemostasis.
Conclusion
To our knowledge post-ES bleeding despite deployment of covered metallic stent has never been reported before. Concomitant epinephrine injection and stenting seem to be effective and synergic to achieve hemostasis. However, we feel that larger size new designed biliary stent will be of immense help in such special scenarios when large biliary duct are present, such as after large ES or dilatation-assisted stone extraction (DASE).
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